Vanden Berghe W - Search Results

1

Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha.

Horion J, Gloire G, El Mjiyad N, Quivy V, Vermeulen L, Vanden Berghe W, Haegeman G, Van Lint C, Piette J, Habraken Y. Horion J, et al. Among authors: vanden berghe w. J Biol Chem. 2007 May 25;282(21):15383-93. doi: 10.1074/jbc.M609166200. Epub 2007 Apr 4. J Biol Chem. 2007. PMID: 17409387 Free article.

2

Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.

Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, Libert C, De Keukeleire D, Essawi T, Haegeman G. Kaileh M, et al. Among authors: vanden berghe w. J Biol Chem. 2007 Feb 16;282(7):4253-4264. doi: 10.1074/jbc.M606728200. Epub 2006 Dec 6. J Biol Chem. 2007. PMID: 17150968 Free article.

3

The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.

Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G. Vanden Berghe W, et al. J Biol Chem. 1999 Nov 5;274(45):32091-8. doi: 10.1074/jbc.274.45.32091. J Biol Chem. 1999. PMID: 10542243 Free article.

4

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).

Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. Vermeulen L, et al. Among authors: vanden berghe w. EMBO J. 2003 Mar 17;22(6):1313-24. doi: 10.1093/emboj/cdg139. EMBO J. 2003. PMID: 12628924 Free PMC article.

5

A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G. Vanden Berghe W, et al. Adv Exp Med Biol. 2003;544:181-96. doi: 10.1007/978-1-4419-9072-3_22. Adv Exp Med Biol. 2003. PMID: 14713228 Review.

6

Regulation of NF-kappaB transcriptional activity.

Vermeulen L, Vanden Berghe W, Haegeman G. Vermeulen L, et al. Among authors: vanden berghe w. Cancer Treat Res. 2006;130:89-102. Cancer Treat Res. 2006. PMID: 16610704 Review.

7

Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity.

Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu MN, Boone E, Haegeman G. Vanden Berghe W, et al. Cancer Res. 2006 May 1;66(9):4852-62. doi: 10.1158/0008-5472.CAN-05-2957. Cancer Res. 2006. PMID: 16651441

8

Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition.

Beck IM, Vanden Berghe W, Vermeulen L, Bougarne N, Vander Cruyssen B, Haegeman G, De Bosscher K. Beck IM, et al. Among authors: vanden berghe w. EMBO J. 2008 Jun 18;27(12):1682-93. doi: 10.1038/emboj.2008.95. Epub 2008 May 29. EMBO J. 2008. PMID: 18511904 Free PMC article.

9

p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G. Vanden Berghe W, et al. J Biol Chem. 1998 Feb 6;273(6):3285-90. doi: 10.1074/jbc.273.6.3285. J Biol Chem. 1998. PMID: 9452444 Free article.

10

Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6.

Vanden Berghe W, Vermeulen L, De Wilde G, De Bosscher K, Boone E, Haegeman G. Vanden Berghe W, et al. Biochem Pharmacol. 2000 Oct 15;60(8):1185-95. doi: 10.1016/s0006-2952(00)00412-3. Biochem Pharmacol. 2000. PMID: 11007957 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters